Free shipping on all orders over $ 500

Lebrikizumab

Cat. No. M25309

All AbMole products are for research use only, cannot be used for human consumption.

Lebrikizumab Structure
Synonym:

TNX-650

Size Price Availability Quantity
100ug USD 160 In stock
1mg USD 270 In stock
5mg USD 720 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Lebrikizumab is a humanized monoclonal antibody to IgG4κ that binds with high affinity and specificity to interleukin 13 (IL-13) and inhibits its function, thereby preventing the formation of the IL-13Rα1/IL-4Rα complex and inhibiting the signaling pathway mediated by this receptor complex.Lebrikizumab has been used in asthma and atopic dermatitis studies. Lebrikizumab may be used in asthma and atopic dermatitis studies.

Chemical Information
CAS Number 953400-68-5
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Jonathan I Silverberg, et al. N Engl J Med. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

[2] Angelina Labib, et al. Clin Cosmet Investig Dermatol. Managing Atopic Dermatitis with Lebrikizumab - The Evidence to Date

[3] Tiffany Y Loh, et al. J Asthma Allergy. Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis

[4] Sabina Antonela Antoniu. Expert Opin Investig Drugs. Lebrikizumab for the treatment of asthma

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Lebrikizumab, TNX-650 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.